tale of woe, page-6

Guys from David Young(MD of Fermiscan)

Mark,
I understand the frustration but the current shareprice is more a reflection of small market cap companies than Fermiscan specific and is a reflection of lack of buying interest.
We are being agressive towards achieving commercialisation in line with our positive announcement on the completion of trial results and we will continue to provide information to the market in a timely and positive manner and an when it is appropriate.
My focus now is investor communication and that will be evidenced in any future announcements.
Thanks for the support.
David